PHARMANET: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMANET
Largest movements
- Intangible fixed assets -€63,753
down €63,753 (-94.1%), from €67,781 to €4,028
- Cash +€63,749
up €63,749 (+14.4%), from €443,420 to €507,169
mainly Net result for the year (+€134,339) and Investment in fixed assets (net) (+€47,496)
- Receivables within one year +€50,258
up €50,258 (+322%), from €15,616 to €65,874
of which Trade receivables: +€50,000
- Profit (loss) carried forward +€34,339
up €34,339 (+18.1%), from €189,988 to €224,327
- Tax, wage and social debts +€16,538
up €16,538 (+35.1%), from €47,127 to €63,665
of which Taxes: +€10,219
- Staff costs +€52,831
up €52,831 (+26.8%), from €196,925 to €249,756
- Gross operating margin +€40,335
up €40,335 (+11.2%), from €361,150 to €401,485
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €529,348 | €579,887 | +€50,539 | +9.5% |
| Fixed assets | 21/28 | €68,007 | €4,254 | -€63,753 | -93.7% |
| Intangible fixed assets | 21 | €67,781 | €4,028 | -€63,753 | -94.1% |
| Financial fixed assets | 28 | €226 | €226 | = | 0.0% |
| Current assets | 29/58 | €461,341 | €575,633 | +€114,292 | +24.8% |
| Amounts receivable within one year | 40/41 | €15,616 | €65,874 | +€50,258 | +322% |
| Trade receivables | 40 | - | €50,000 | +€50,000 | |
| Other amounts receivable | 41 | €15,616 | €15,874 | +€258 | +1.7% |
| Cash at bank and in hand | 54/58 | €443,420 | €507,169 | +€63,749 | +14.4% |
| Deferred charges and accrued income | 490/1 | €2,305 | €2,590 | +€285 | +12.4% |
| Total equity and liabilities | 10/49 | €529,348 | €579,887 | +€50,539 | +9.5% |
| Equity | 10/15 | €381,883 | €416,222 | +€34,339 | +9.0% |
| Contributions | 10/11 | €174,300 | €174,300 | = | 0.0% |
| Capital | 10 | €174,300 | €174,300 | = | 0.0% |
| Issued capital | 100 | €174,300 | €174,300 | = | 0.0% |
| Reserves | 13 | €17,595 | €17,595 | = | 0.0% |
| Non-distributable reserves | 130/1 | €17,430 | €17,430 | = | 0.0% |
| Legal reserve | 130 | €17,430 | €17,430 | = | 0.0% |
| Distributable reserves | 133 | €165 | €165 | = | 0.0% |
| Profit (loss) carried forward | 14 | €189,988 | €224,327 | +€34,339 | +18.1% |
| Amounts payable | 17/49 | €147,465 | €163,665 | +€16,200 | +11.0% |
| Amounts payable within one year | 42/48 | €147,465 | €163,665 | +€16,200 | +11.0% |
| Trade debts | 44 | €338 | - | -€338 | |
| Suppliers | 440/4 | €338 | - | -€338 | |
| Taxes, remuneration and social security | 45 | €47,127 | €63,665 | +€16,538 | +35.1% |
| Taxes | 450/3 | €21,989 | €32,208 | +€10,219 | +46.5% |
| Remuneration and social security | 454/9 | €25,138 | €31,457 | +€6,319 | +25.1% |
| Other amounts payable | 47/48 | €100,000 | €100,000 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €196,925 | €249,756 | +€52,831 | +26.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,510 | €16,257 | -€1,253 | -7.2% |
| Other operating charges | 640/8 | €967 | €400 | -€567 | -58.6% |
| Non-recurring operating charges | 66A | €46,757 | - | -€46,757 | |
| Gross operating margin | 9900 | €361,150 | €401,485 | +€40,335 | +11.2% |
| Operating profit (loss) | 9901 | €98,991 | €135,072 | +€36,081 | +36.4% |
| Financial income | 75/76B | €3,235 | €4 | -€3,231 | -99.9% |
| Recurring financial income | 75 | €3,235 | €4 | -€3,231 | -99.9% |
| Financial charges | 65/66B | €674 | €737 | +€63 | +9.3% |
| Recurring financial charges | 65 | €674 | €737 | +€63 | +9.3% |
| Profit (loss) for the period before taxes | 9903 | €101,552 | €134,339 | +€32,787 | +32.3% |
| Profit (loss) for the period | 9904 | €101,552 | €134,339 | +€32,787 | +32.3% |
| Profit (loss) for the period to be appropriated | 9905 | €101,552 | €134,339 | +€32,787 | +32.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.